These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23642452)

  • 1. Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.
    Gromadzka G; Karlińska AG; Łysiak Z; Błażejewska-Hyżorek B; Litwin T; Członkowska A
    J Neuroimmunol; 2013 Jun; 259(1-2):75-80. PubMed ID: 23642452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of paraneoplastic disease associated with lymphoma.
    Briani C; Vitaliani R; Grisold W; Honnorat J; Graus F; Antoine JC; Bertolini G; Giometto B;
    Neurology; 2011 Feb; 76(8):705-10. PubMed ID: 21339498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
    Fu P; He L; Tang N; Nie Q; Li Z
    J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological paraneoplastic syndromes in lung cancer patients.
    Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
    Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
    Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
    J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin-4 autoantibodies in a paraneoplastic context.
    Pittock SJ; Lennon VA
    Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
    Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
    J Biosci; 2021; 46():. PubMed ID: 33709965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
    Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
    Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic neurological syndrome and autoantibodies].
    Hayashi Y; Inuzuka T
    Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex serology of paraneoplastic antineuronal antibodies.
    Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
    J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
    Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onconeural antibodies: improved detection and clinical correlations.
    Storstein A; Monstad SE; Haugen M; Mazengia K; Veltman D; Lohndal E; Aarseth J; Vedeler C
    J Neuroimmunol; 2011 Mar; 232(1-2):166-70. PubMed ID: 21093932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
    Raspotnig M; Vedeler CA; Storstein A
    Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
    Storstein A; Vedeler CA
    Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.